Mark Anzalone
About Mark Anzalone
Mark Anzalone is a Principal Regulatory Affairs Specialist at Boston Scientific with extensive experience in regulatory affairs and a strong educational background in biological sciences.
Principal Regulatory Affairs Specialist at Boston Scientific
Mark Anzalone currently holds the position of Principal Regulatory Affairs Specialist at Boston Scientific. He has been in this role since 2021 and operates from Marlborough, Massachusetts. His role likely involves ensuring compliance with regulatory requirements and managing submission processes for medical devices.
Past Experience at Haemonetics
Before joining Boston Scientific, Mark Anzalone worked at Haemonetics in several capacities. From 2018 to 2021, he served as a Manager in Regulatory Affairs in Boston, Massachusetts. Prior to that, he was a Senior Regulatory Affairs Specialist from 2016 to 2018 and a Regulatory Affairs Specialist from 2014 to 2016, both in Braintree, MA. His progressive roles at Haemonetics highlight his growing expertise and responsibility in regulatory affairs.
Regulatory Affairs Associate at Fresenius Medical Care
Mark Anzalone started his career in regulatory affairs at Fresenius Medical Care. He served as a Regulatory Affairs Associate I from 2012 to 2014 in Waltham, MA. This role provided him foundational experience in the regulatory landscape of medical devices.
Master of Science in Biology from University of Massachusetts Lowell
Mark Anzalone earned a Master of Science (MS) degree in Biology/Biological Sciences from the University of Massachusetts Lowell. He studied there from 2010 to 2012. This advanced education equipped him with essential scientific knowledge that supports his regulatory affairs expertise.
Bachelor of Arts in Molecular Biology from Assumption College
Mark Anzalone obtained a Bachelor of Arts (BA) in Molecular Biology and Biotechnology from Assumption College, where he studied from 2006 to 2010. This degree provided him with a strong foundation in the biological sciences, which is crucial for his roles in the regulatory affairs sector.